Literature DB >> 32781860

Simple Vision Function Tests that Distinguish Eyes with Early to Intermediate Age-related Macular Degeneration.

Lori A Lott1, Marilyn E Schneck1, Gunilla Haegerstrom-Portnoy1,2, Susan Hewlett1,2, Natalie Stepien-Bernabe1, Bonnie M Gauer3, Ali Zaidi4, Arthur D Fu5, John A Brabyn1.   

Abstract

PURPOSE: To present and compare baseline vision findings in eyes with early age-related macular degeneration (E-AMD), intermediate AMD (I-AMD), and age-similar participants with normal aging changes to the retina (No-AMD).
METHODS: Two hundred and thirty-seven eyes of 125 individuals (66.4% female, mean age 75.3 years) were tested monocularly using several simple, rapid psychophysical tests: high contrast visual acuity, low contrast visual acuity at reduced luminance, contrast sensitivity, shape discrimination hyperacuity, colour vision, reading rate, and glare recovery. Retinal status was determined using colour fundus photographs that were graded according to the Beckman Initiative for Macular Research Classification Committee scale. Logistic regression analyses with generalized estimating equations were used to assess the association between each vision variable and AMD category, while taking into account the correlation between the two eyes.
RESULTS: Three vision measures (contrast sensitivity [CS], shape discrimination hyperacuity [SDH], and colour discrimination [DesatCCS]) were significantly and independently associated with intermediate AMD. Relative Risk Ratios (RRR), 95% Confidence Intervals (in parentheses), beta coefficients, and significance (p) for the I-AMD vs. No-AMD model are: CS: RRR = 6.5 (1.91-22.0), beta = 1.87, p < .01; SDH: RRR = 2.34 (1.24-4.44), beta = 0.85, p < .001; DesatCCS: RRR = 1.43 (1.22-1.68), beta = 0.36, p < .001. Performance on these measures was significantly poorer for participants with I-AMD vs. No-AMD.
CONCLUSIONS: Simple screening tests distinguish eyes with intermediate AMD from eyes with less severe AMD or normal aging changes. This suggests that these vision measures may be significant predictors of which participants will go on to develop advanced AMD.

Entities:  

Mesh:

Year:  2020        PMID: 32781860      PMCID: PMC7878586          DOI: 10.1080/09286586.2020.1793371

Source DB:  PubMed          Journal:  Ophthalmic Epidemiol        ISSN: 0928-6586            Impact factor:   1.648


  55 in total

1.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

2.  Circular contour frequency in shape discrimination.

Authors:  Brett G Jeffrey; Yi Zhong Wang; Eileen E Birch
Journal:  Vision Res       Date:  2002-11       Impact factor: 1.886

3.  Standardized assessment of reading performance: the New International Reading Speed Texts IReST.

Authors:  Susanne Trauzettel-Klosinski; Klaus Dietz
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-08-13       Impact factor: 4.799

4.  Relationship between clinical macular changes and retinal function in age-related macular degeneration.

Authors:  Peter N Dimitrov; Liubov D Robman; Mary Varsamidis; Khin Zaw Aung; Galina Makeyeva; Lucy Busija; Algis J Vingrys; Robyn H Guymer
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-08-07       Impact factor: 4.799

5.  A simplified severity scale for age-related macular degeneration: AREDS Report No. 18.

Authors:  Frederick L Ferris; Matthew D Davis; Traci E Clemons; Li-Yin Lee; Emily Y Chew; Anne S Lindblad; Roy C Milton; Susan B Bressler; Ronald Klein
Journal:  Arch Ophthalmol       Date:  2005-11

6.  Delays in rod-mediated dark adaptation in early age-related maculopathy.

Authors:  C Owsley; G R Jackson; M White; R Feist; D Edwards
Journal:  Ophthalmology       Date:  2001-07       Impact factor: 12.079

Review 7.  Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study.

Authors:  P Mitchell; W Smith; K Attebo; J J Wang
Journal:  Ophthalmology       Date:  1995-10       Impact factor: 12.079

8.  Orientation discrimination with macular changes associated with early AMD.

Authors:  Harold E Bedell; Jianliang Tong; Stanley Y Woo; Jon R House; Tammy Nguyen
Journal:  Optom Vis Sci       Date:  2009-05       Impact factor: 1.973

9.  Seven-year outcomes in ranibizumab-treated patients in ANCHOR, MARINA, and HORIZON: a multicenter cohort study (SEVEN-UP).

Authors:  Soraya Rofagha; Robert B Bhisitkul; David S Boyer; SriniVas R Sadda; Kang Zhang
Journal:  Ophthalmology       Date:  2013-05-03       Impact factor: 12.079

10.  Performance, usability and comparison of two versions of a new macular vision test: the handheld Radial Shape Discrimination test.

Authors:  Jae Y Ku; Ashli F Milling; Noelia Pitrelli Vazquez; Paul C Knox
Journal:  PeerJ       Date:  2016-11-01       Impact factor: 2.984

View more
  3 in total

1.  Visual Function in Eyes with Intermediate AMD with and without Retinal Pigment Abnormalities.

Authors:  Marilyn E Schneck; Lori A Lott; Gunilla Haegerstrom-Portnoy; Susan Hewlett; Bonnie M Gauer; Ali Zaidi
Journal:  Optom Vis Sci       Date:  2021-01-01       Impact factor: 2.106

2.  How Vision Is Impaired From Aging to Early and Intermediate Age-Related Macular Degeneration: Insights From ALSTAR2 Baseline.

Authors:  Cynthia Owsley; Thomas A Swain; Gerald McGwin; Mark E Clark; Deepayan Kar; Jason N Crosson; Christine A Curcio
Journal:  Transl Vis Sci Technol       Date:  2022-07-08       Impact factor: 3.048

3.  Longitudinal Evaluation of Visual Function Impairments in Early and Intermediate Age-Related Macular Degeneration Patients.

Authors:  Eleonora M Lad; Vivienne Fang; Michel Tessier; Anna Rautanen; Javier Gayan; Sandra S Stinnett; Ulrich F O Luhmann
Journal:  Ophthalmol Sci       Date:  2022-05-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.